Development Level

Tbio 2 | 10,625

IMPC Term

abnormal tooth morphology 1 | 24
decreased circulating glucose ... 1 | 121
decreased circulating lipase l... 1 | 2
decreased circulating serum al... 1 | 79
decreased circulating sodium l... 1 | 18
decreased threshold for audito... 1 | 32
increased circulating HDL chol... 1 | 63
increased circulating LDL chol... 1 | 15
increased circulating alkaline... 1 | 119
increased circulating bilirubi... 1 | 16
increased circulating choleste... 1 | 53
increased circulating free fat... 1 | 17
increased circulating triglyce... 1 | 24
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 25
preweaning lethality, complete... 1 | 633

Disease

glioblastoma 2 | 5,572
medulloblastoma, large-cell 2 | 6,234
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
psoriasis 2 | 6,685
ALZHEIMER DISEASE 2 1 | 1
Abdominal aortic aneurysm 1 | 9
Adenocarcinoma 1 | 115
Age related macular degeneration 1 | 84
Alzheimer's disease 1 | 644
Amyloidosis 1 | 68
Aphasia 1 | 22
Arteriosclerosis 1 | 5
Atherosclerosis 1 | 275
Atopic dermatitis 1 | 944
Brain disease 1 | 83
CORONARY ARTERY DISEASE, SEVERE, SUSCEPTIBILITY TO 1 | 1
Cancer 1 | 2,346
Cardiovascular Diseases 1 | 50
Cardiovascular system disease 1 | 194
Carotid Artery Diseases 1 | 11
Carotid stenosis 1 | 5
Cerebral amyloid angiopathy 1 | 9
Cerebrovascular disease 1 | 231
Cognition Disorders 1 | 23
Combined molybdoflavoprotein enzyme deficiency 1 | 3
Coronary artery disease 1 | 240
Coronary heart disease 1 | 59
Dementia 1 | 129
Down syndrome 1 | 548
Drug-Induced Liver Injury 1 | 118
Duchenne muscular dystrophy 1 | 602
Familial hyperlipidemia 1 | 6
Heart disease 1 | 279
Hepatolenticular Degeneration 1 | 24
Hypercholesterolemia 1 | 27
Hypercholesterolemia, Familial 1 | 16
Hyperglycemia 1 | 120
Hyperhomocysteinemia 1 | 34
Hyperlipidemia 1 | 25
Hyperlipoproteinemia Type III 1 | 3
Hyperlipoproteinemias 1 | 6
Hypertension 1 | 287
Hypertensive disease 1 | 193
Impaired cognition 1 | 4
Kidney disease 1 | 396
LIPOPROTEIN GLOMERULOPATHY 1 | 1
Leishmaniasis 1 | 49
Lewy Body Disease 1 | 19
Lipid metabolism disorder 1 | 102
Liver disease 1 | 219
Lung Neoplasms 1 | 171
Lysosomal storage disease 1 | 11
Macular Degeneration, Age-Related, 1 1 | 9
Mental deterioration 1 | 4
Mercury Poisoning 1 | 1
Metabolic syndrome X 1 | 155
Multiple Sclerosis 1 | 498
Multiple Sclerosis, Relapsing-Remitting 1 | 2
Myocardial Infarction 1 | 126
Nerve Degeneration 1 | 73
Neurodegenerative disease 1 | 383
Obesity 1 | 616
Parkinson's disease 1 | 364
Pathological accumulation of air in tissues 1 | 11
Pick disease 1 | 1,893
Plaque, Atherosclerotic 1 | 3
Proteinuria 1 | 63
Renal Insufficiency 1 | 10
Schizophrenia 1 | 501
Sea-Blue Histiocyte Syndrome 1 | 3
Seizures 1 | 95
Splenomegaly 1 | 7
Spontaneous abortion 1 | 108
Toxic encephalopathy 1 | 131
acute quadriplegic myopathy 1 | 1,157
adrenocortical carcinoma 1 | 1,427
astrocytic glioma 1 | 2,241
diabetes mellitus 1 | 1,663
esophageal adenocarcinoma 1 | 737
gastric carcinoma 1 | 832
group 3 medulloblastoma 1 | 2,254
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hearing impairment 1 | 40
hereditary spastic paraplegia 1 | 313
interstitial cystitis 1 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
invasive ductal carcinoma 1 | 2,950
juvenile dermatomyositis 1 | 1,189
medulloblastoma 1 | 1,524
nasopharyngeal carcinoma 1 | 1,056
nephrosclerosis 1 | 329
non primary Sjogren syndrome sicca 1 | 840
oligodendroglioma 1 | 2,849
osteosarcoma 1 | 7,933
ovarian cancer 1 | 8,484
pediatric high grade glioma 1 | 2,712
tuberculosis and treatment for 6 months 1 | 686
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 2 | 17,995
Cardiovascular System 2 | 17,958
Digestive Tract 2 | 18,473
Endocrine System 2 | 18,512
Female tissues 2 | 18,647
Liver and Pancreas 2 | 18,136
Male tissues 2 | 17,969
Nervous System 2 | 18,561
Respiratory system 2 | 17,484
Skin and soft tissues 2 | 18,115
Urinary Tract 2 | 18,444

Target Family

Enzyme 1 | 4,146
Non-IDG 1 | 11,971

Grant Application

2R01AI020941-19 2 | 2
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Apolipoprotein E APOE Tbio Non-IDG -4.17470 15380.4 788
Molybdopterin synthase sulfur carrier subunit MOCS2 Tbio Enzyme -2.27866 193.7 72